ALPK1 and retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome: These results demonstrate the ability of DF-003 to inhibit ALPK1[T237M]-induced cytokine expression in this mouse model of ROSAH syndrome.